Fourth quarter 2025 total revenue expected to be approximately $11.3 million, representing growth of approximately 37% ...

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission ...

Rapid Micro Biosystems shares rose after the company shared preliminary sales results that were ahead of Wall Street estimates. The stock advanced 13% to $3.44 in after-hours trading Tuesday. Through ...

Rapid Micro Biosystems (NASDAQ:RPID) is preparing to release its quarterly earnings on Friday, 2025-05-09. Here's a brief overview of what investors should keep in mind before the announcement.

TG Therapeutics raised its guidance for the fiscal year. Shares rose 7% to $29.84 in after-hours trading. Rapid Micro Biosystems published preliminary sales results that were ahead of expectations.

LOWELL, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to ...

Reports first quarter 2024 total revenue of $5.6 million, representing growth of 11% compared to first quarter 2023 Reaffirms full year 2024 total revenue guidance of at least $27.0 million, ...

American Century Companies Inc. acquired a new position in Rapid Micro Biosystems, Inc. (NASDAQ:RPID – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The ...

White Brook Capital Partners, an investment management firm, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. White Brook Capital’s middle capitalization ...

Robert Spignesi, CEO, opened by highlighting third quarter revenue of $7.8 million, which was above the midpoint of guidance and marked the twelfth consecutive quarter meeting or beating revenue ...

We can readily understand why investors are attracted to unprofitable companies. By way of example, Rapid Micro Biosystems (NASDAQ:RPID) has seen its share price rise 250% over the last year, ...

Initiating Rapid Micro Biosystems at 'buy' with $4.60 fair value, driven by strong growth potential in automated microbial quality control market. Growth Direct platform offers clear advantages over ...